Back to results
US 2004/0082562 A1Published application
Novel inhibitors of IMPDH enzyme
AssigneeBristol-Myers Squibb Company
InventorsHenry H. Gu, T.G. Murali Dhar, Edwin J. Iwanowicz
Life of this patent
Estimating the term…
Abstract
The present invention discloses the identification of the novel inhibitors of IMPDH (inosine-5′-monophosphate dehydrogenase). The compounds and pharmaceutical compositions disclosed herein are useful in treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases.
Claims22
A compound of the following formula I, or a pharmaceutically acceptable salt thereof:
- 133
- wherein:
- Z is a monocyclic or bicyclic ring system optionally containing up to 4 heteroatoms selected from N, O, and S, and wherein a CH2 adjacent to any of the said N, O or S heteroatoms is optionally substituted with oxo (═O), and wherein Z is optionally substituted with 0-5 substituents chosen from R1, R2, R3 or R4;
- R1 and R2 are each independently selected from the group consisting of H, F, Cl, Br, I, NO2, CF3, CN, OCF3, OH, C1-C4alkoxy-, C1-C4alkylcarbonyl-, C1-C6 alkyl, hydroxy C1-C4 alkyl-, C3-C6 alkenyl, C3-C6 alkynyl, C3-C10 cycloalkyl(C0-C4alkyl)-, H2N(C0-C4)alkyl-, R6HN(C0-C4)alkyl-, R6R7N(C0-C4)alkyl-, R7S(C0-C4)alkyl-, R7S(O)(C0-C4)alkyl-, R7SO2(C0-C4)alkyl-, R6NSO2(C0-C4)alkyl-, HSO3, HO2C(C0-C4)alkyl-, R6O2C(C0-C4)alkyl-, and R6R7NCO(C0-C4)alkyl-, or
- alternatively, R1 and R2, when on adjacent carbon atoms, may be taken together to be methylenedioxy or ethylenedioxy;
- R3 is a 5- or 6-membered heterocyclic ring system containing up to 4 heteroatoms selected from N, O, and S, said heterocyclic ring system being optionally substituted with 0-3 R5, wherein when R5 is hydroxy the heterocycle may undergo tautomerization to an oxo species or may exist as an equilibrium mixture of both tautomers;
- R4 is selected from F, Cl, Br, I, NO2, CF3, CN, C1-C4alkoxy-, OH, oxo, CF3O, haloalkyloxy, C0-C4 alkylhydroxy, C1-C4 alkyl-, C1-C4alkylcarbonyl-, C0-C4 alkylOCOR6, C0-C4 alkylOC(═O)OR6, C0-C4 alkylOC(═O)NR6R7, NH2, NHR6, C0-C4 alkylNR6R7, C0-C4 alkylNR7C(═O)OR6, C0-C4 alkylNR6SO2NR6R7, C0-C4 alkylNR7SO2R6, C0-C4 alkylSR6, C0-C4 alkylS(O)R6, C0-C4 alkylSO2R6, SO3R7, C0-C4 alkylSO2NR6R7, C0-C4alkyl SO2NR7CO(CR9R10)0-3R6, C0-C4 alkylCO2H, C0-C4 alkylCO2R6, C0-C4 alkylCONR6R7, and C0-C4alkylCONR7SO2(CR9R10)0-3R6;
- R5 is selected from the group consisting of H, C1-C4 alkyl, C3-C7 cycloalkyl, F, Cl, Br, I, NO2, CN, CF3, OCF3, OH, oxo, C1-C4alkoxy-, hydroxyC1-C4 alkyl-, C1-C4 alkylcarbonyl-, CO2H, CO2R6, CONR6R7, NHR6, and NR6R7;
- R6 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic (C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, hydroxy C0-C4 alkyl, oxo, F, Cl, Br, CF3, NO2, CN, OCF3, NH2, NHR7, NR7R8, SR7, S(O)R7, SO2R7, SO2NR7R8, CO2H, CO2R7, and CONR7R8;
- R7 and R8 are each independently selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, aryl(C1-C5 alkoxy)carbonyl, arylsulfonyl, aryl(C0-C4 alkyl)-, heterocyclic(C1-C5 alkoxy)carbonyl, heterocyclic sulfonyl and heterocyclic (C0-C4 alkyl)-, wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- alternatively, R6 and R7, or R6 and R8, or R7 and R8, when both substituents are on the same nitrogen atom, can be taken together with the nitrogen atom to which they are attached to form a heterocycle selected from the group consisting of 1-aziridinyl, 1-azetidinyl, 1-piperidinyl, 1-morpholinyl, 1-pyrrolidinyl, thiamorpholinyl, thiazolidinyl, and 1-piperazinyl, said heterocycle being optionally substituted with 0-3 groups selected from the group consisting of oxo, C1-C6 alkyl, C3-C7 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, aryl(C0-C5 alkyl), heterocycdic(C0-C5 alkyl), aryl(C1-C5 alkoxy)carbonyl, heterocyclic(C1-C5 alkoxy)carbonyl, C1-C6 alkylsulfonyl, arylsulfonyl, and heterocyclicsulfonyl,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- J is selected from the group consisting of —NR7— and —C(═O)—;
- K is selected from the group consisting of —NR7—, —C(═O)—, and —CHR9—;
- L is selected from the group consisting of a single bond, —C(═O), —CR10R11—, —C(═O)CR10R11—, —CR10R11C(═O)—, —CR10R11C(═O)—, —HR15C—CHR16—, and —R15C═CR16;
- R9 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, and NO2;
- R10 is selected from the group consisting of H, F, Cl, Br, C1-C6 alkoxy, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-, wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- R11 is selected from the group consisting of H, F, Cl, Br, OMe, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-, wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- alternatively, R10 and R11, when on the same carbon atom, can be taken together with the carbon atoms to which they are attached to form a 3-7 membered carbocyclic or 3-7 membered heterocyclic non-aromatic ring system, said carbocyclic or heterocyclic ring being optionally substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, hydroxy C0-C4 alkyl, oxo, F, Cl, Br, CF3, and NO2;
- X is selected from the group consisting of OR12, NR12R13, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, C6-C10 aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-3 substituents independently selected from R14, with the proviso that when L is a single bond, X cannot be NR12R13;
- R12 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, monocyclic or bicyclic aryl(C0-C4 alkyl)-, and monocyclic or bicyclic 5-10 membered heterocyclic(C0-C4 alkyl)-, and —CZ1Z2Z3,
- wherein said aryl or heterocyclic groups are substituted with 0-3 substituents independently selected from R14;
- Z1 is selected from the group consisting of C1-C8 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 hydroxyalkyl, C1-C4 alkoxy C1-C4 alkyl, aryl(C0-C4 alkyl)-, and 4-10 membered heterocyclic (C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-3 substituents independently selected from R14;
- Z2 is selected from the group consisting of C1-C8 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 hydroxyalkyl, C1-C4 alkoxy C1-C4 alkyl, C1-C6 NR17R18, aryl(C0-C4 alkyl)-, and 4-10 membered heterocyclic (C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-3 substituents independently selected from R14;
- Z3 is selected from the group consisting of C1-C8 alkyl, R14(C2-C4 alkyl)-, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 hydroxyalkyl, C1-C4 alkoxy C1-C4 alkyl, aryl(C0C4 alkyl)-, 4-10 membered heterocyclic (C0-C4 alkyl)-, R17O═C(C0-C4 alkyl)-, R17OO═C(C0-C4 alkyl)-, and R17R18NO═C(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-3 substituents independently selected from R14;
- alternatively, Z1 and Z2, when on the same carbon atom, can be taken together with the carbon atoms to which they are attached to form a 3-7 membered carbocyclic or 3-7 membered heterocyclic non-aromatic ring system, said carbocyclic or heterocyclic ring being optionally substituted with 0-2 substituents independently selected from R14.
- R13 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C1-C6 alkylsulfonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, aryl(C0-C4 alkyl)-, aryl(C1-C5 alkoxy)carbonyl , arylsulfonyl, heterocyclic(C0-C4 alkyl), heterocyclic(C1-C5 alkoxy)carbonyl, and heterocyclicsulfonyl,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- alternatively, R12 and R13, when both are on the same nitrogen atom, can be taken together with the nitrogen atom to which they are attached to form a heterocycle selected from 1-aziridinyl, 1-azetidinyl, 1-piperidinyl, 1-morpholinyl, 1-pyrrolidinyl, thiamorpholinyl, thiazolidinyl, and 1-piperazinyl,
- said heterocycle being optionally substituted with 0-3 groups independently selected from oxo, C1-C6 alkyl, C3-C7 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, heterocyclic(C1-C5 alkoxy)carbonyl, C1-C6 alkylsulfonyl arylsulfonyl and heterocyclicsulfonyl,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of CH3—, alkoxy, F, Cl, Br, CF3, CN, and NO2;
- R14 is selected from the group consisting of H, C1-C10 alkyl, NO2, CF3, CN, F, Cl, Br, C1-C10 alkylcarbonyl, haloalkyl, haloalkoxy, OH, NR6R7(C0-C4 alkyl)-, R6C(═O)O(C0-C4 alkyl)-, R6OC(═O)O(C0-C4 alkyl)-, R6O(C0-C4 alkyl), R6R7NC(═O)O(C0-C4 alkyl)-, R6R7NC(═O)(C0-C4 alkyl)-, R6O(CR10R11)2-6R6NC(═O)(C0-C4 alkyl)-, R6R7N(CR10R11)2-6R6NC(═O)(C0-C4 alkyl)-, R6O2C(CH2)1-4O(C0-C4 alkyl)-, R6OOC(C1-C4 alkoxy)-, R6OOC(C0-C4 alkyl)-, R6C(═O)(C0-C4 alkyl)-, R6C(═O)NR7(C0-C4 alkyl)-, R6OC(═O)NR7(C0-C4 alkyl)-, R6OC(═NCN)NR7(C0-C4 alkyl)-, R6R7NC(═O)NR8(C0-C4 alkyl)-, R6OC(═NC)NR7(C0-C4 alkyl)-, R6(CR10R11)1-4 NR7C═O—, R6O(CR10R11)1-4O═CR7N—, NR6R7(CR10R11)1-4 C═O R7N—, R6O(CR10R11)2-4R7N—, R6O2C(CR10R11)1-4R7N, R6R7N(CR10R11)2-4R7N—, R6R7NC(═NCN)NR7(C0-C4 alkyl)-, R6R7NC(═C(H)(NO2))NR7(C0-C4 alkyl)-, R7R8NC(═NR7)NR7(C0-C4 alkyl)-, R6R7N SO2NR8(C0-C4 alkyl)-, R6SO2NR7(C0-C4 alkyl)-, R6R7N(C1-C4)CO—, R6R7N(C2-C6 alkyl)O—, R6CO(CR10R11)0-2 R7N(O2)S(C0-C4 alkyl), R6(O2)S R7NC(═O)(C0-C4 alkyl)-, R6S(C0-C4 alkyl)-, R6S(═O)(C0-C4 alkyl)-, R6SO2(C0-C4 alkyl)-, SO2NR6R7, SiMe3, R6R7N(C2-C4 alkyl)-, R6R7N(C2-C4 alkoxy)-, HSO3, HONH—, R6ONH—, R8R7NNR6—, HO(COR6)N—, HO(R6O2C)N, C2-C6 alkenyl, C3-C10 cycloalkyl, C3-C10 cycloalkylmethyl, aryl(C0-C4alkyl)-, heteroaryl(C0-C4alkyl)-, aryl(C0-C4alkyl)O—, and heteroaryl(C0-C4alkyl)O—,
- wherein said aryl groups are substituted with 0-2 substituents independently selected from a group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, and NO2;
- R15 is selected from the group consisting of H, halo, cyano, C1-C8 alkyl, C3-C6 alkenyl, and C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from R14;
- and
- R16 is selected from the group consisting of H, halo, cyano, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from R14;
- alternatively, when R15 and R16 are on adjacent carbon atoms, or when R15 and R16 are oriented on the same side of the double bond, as depicted in the following structure (III)
- 134
- R15 and R16 can be taken together with the carbon atoms to which they are attached to form a 3-7 membered carbocyclic aromatic or nonaromatic ring system, or a 3-7 membered heterocyclic aromatic or nonaromatic ring system, said carbocyclic or heterocyclic ring being optionally substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, NO2;
- R17 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C1-C6 alkylsulfonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, hydroxy(C2-C4)alkyl-, C1-C3 alkoxy(C2-C4)alkyl-, (C0-C4 alkyl)(C0-C4 alkyl) amino(C2-C4)alkyl-, aryl(C0-C4 alkyl)-, aryl(C1-C5 alkoxy)carbonyl, arylsulfonyl, heterocyclic(C0-C4 alkyl), heterocyclic(C1-C5 alkoxy)carbonyl, and heterocyclicsulfonyl,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkoxy C1-C4 alkyl, oxo, F, Cl, Br, CF3, CN, and NO2;
- R18 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl),
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- and
- alternatively, R17 and R18, when both are on the same nitrogen atom, can be taken together with the nitrogen atom to which they are attached to form a heterocycle selected from 1-aziridinyl, 1-azetidinyl, 1-piperidinyl, 1-morpholinyl, 1-pyrrolidinyl, thiamorpholinyl, thiazolidinyl, and 1-piperazinyl,
- said heterocycle being optionally substituted with 0-3 groups selected from oxo, C1-C6 alkyl, C3-C7 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, (C1-C6 alkylcarbonyl)(C0-C4alkyl)amino-, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, aryl(C0-C5 alkyl), heterocyclic(C0-C5 alkyl), aryl(C1-C5 alkoxy)carbonyl, heterocyclic(C1-C5 alkoxy)carbonyl, C1-C6 alkylsulfonyl arylsulfonyl and heterocyclicsulfonyl,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of CH3—, alkoxy, F, Cl, Br, CF3, CN, and NO2.
52 more elements
A compound of the following Formula I, or a pharmaceutically acceptable salt thereof:
- 135
- wherein:
- (1) Z is a saturated, partially saturated or unsaturated monocyclic or bicyclic ring system optionally containing up to 4 heteroatoms selected from N, O, and S, and wherein a CH2 adjacent to any of the said N, O or S heteroatoms is optionally substituted with oxo (═O), and wherein Z is optionally substituted with 0-3 substituents chosen from R1, R2, R3 or R4;
- (2) R1 and R2 are independently selected from the group consisting of H, F, Cl, Br, I, NO2, CF3, CN, OCF3, OH, C1-C4alkoxy-, C1-C4alkylcarbonyl-, C1-C6 alkyl, hydroxy C1-C4 alkyl-, C3-C6 alkenyl, C3-C6 alkynyl, C3-C10 cycloalkyl(C0-C4alkyl)-, H2N(C0-C4)alkyl-, R6HN(C0-C4)alkyl-, R6R7N(C0-C4)alkyl-, R7S(C0-C4)alkyl-, R7S(O)(C0-C4)alkyl-, R7SO2(C0-C4)alkyl-, R6NSO2(C0-C4)alkyl-;
- HSO3, HO2C(C0-C4)alkyl-, R6O2C(C0-C4)alkyl-, and R6R7NCO(C0-C4)alkyl-;
- alternatively, R1 and R2, when on adjacent carbon atoms, may be taken together to be methylenedioxy or ethylenedioxy;
- (3) R3 is a 5- or 6-membered heterocyclic ring system containing up to 4 heteroatoms selected from N, O, and S, said heterocyclic ring system being optionally substituted with 0-3 R5, when R5 is hydroxy the heterocycle may undergo tautomerization to an oxo species, or exist as an equilibrium mixture of both tautomers;
- (4) R4 is selected from the group consisting of H, F, Cl, Br, I, NO2, CF3, CN, OCF3, OH, C1-C4alkoxy-, hydroxyC1-C4 alkyl-, C1-C4 alkylcarbonyl-, NH2, NHR6, NR6R7, SR6, S(O)R6, SO2R6, SO2NR6R7, CO2H, CO2R6, and CONR6R7;
- (5) R5 is selected from the group consisting of H, F, Cl, Br, I, NO2, CN, CF3, OCF3, OH, oxo, C1-C4alkoxy-, hydroxyC1-C4 alkyl-, C1-C4 alkylcarbonyl-, CO2H, CO2R6, CONR6R7, NHR6, and NR6R7;
- (6) R6 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic (C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, hydroxy C0-C4 alkyl, oxo, F, Cl, Br, CF3, NO2, CN, OCF3, NH2, NHR7, NR7R8, SR7, S(O)R7, SO2R7, SO2NR7R8, CO2H, CO2R7, and CONR7R8;
- (7) R7 and R8 are independently selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, aryl(C1-C5 alkoxy)carbonyl, arylsulfonyl, aryl(C0-C4 alkyl)-, heterocyclic(C1-C5 alkoxy)carbonyl, heterocyclic sulfonyl and heterocyclic (C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- (8) alternatively, R6 and R7, or R6 and R8, or R7 and R8, when both substituents are on the same nitrogen atom [as in (—NR6R7) or (—NR7R8)], can be taken together with the nitrogen atom to which they are attached to form a heterocycle selected from the group consisting of 1-aziridinyl, 1-azetidinyl, 1-piperidinyl, 1-morpholinyl, 1-pyrrolidinyl, thiamorpholinyl, thiazolidinyl, and 1-piperazinyl, said heterocycle being optionally substituted with 0-3 groups selected from the group consisting of oxo, C1-C6 alkyl, C3-C7 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, aryl(C0-C5 alkyl), heterocyclic(C0-C5 alkyl), aryl(C1-C5 alkoxy)carbonyl, heterocyclic(C1-C5 alkoxy)carbonyl, C1-C6 alkylsulfonyl, arylsulfonyl, and heterocyclicsulfonyl,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- (9) J is selected from the group consisting of —NR7—, and —C(═O)—;
- (10) K is selected from the group consisting of —NR7—, —C(═O)—, and —CHR9—;
- (11) L is selected from the group consisting of a single bond (i.e., L is absent), —C(═O), —CHR9—, —C(═O)CHR10—, —CHR10C(═O)—, —CR10R11C(═O)—, —HR15C—CHR16—, and —R15C═CR16—;
- (12) R9 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, and NO2;
- (13) R10 is selected from the group consisting of H, F, Cl, Br, C1-C6 alkoxy, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-, wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- (14) R11 is selected from the group consisting of H, F, Cl, Br, OMe, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-, wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- (15) alternatively, R10 and R11, when on the same carbon atom [as in (—CR10R11—)], can be taken together with the carbon atoms to which they are attached to form a 3-7 membered carbocyclic or 3-7 membered heterocyclic non-aromatic ring system, said carbocyclic or heterocyclic ring being optionally substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, hydroxy C0-C4 alkyl, oxo, F, Cl, Br, CF3, NO2;
- (16) X is selected from the group consisting of OR12, NR12R13, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, C6-C10 aryl(C0-C4 alkyl)-, —CR4═CR5(heteroaryl), —CR4═CR5(aryl), and heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-3 substituents independently selected from R14, with the proviso that when L is a single bond (i.e., L is absent), X cannot be NR12R13;
- (17) R12 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and 4-10 membered heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-3 substituents independently selected from R14;
- (18) R13 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C1-C6 alkylsulfonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, aryl(C0-C4 alkyl)-, aryl(C1-C5 alkoxy)carbonyl, arylsulfonyl, heterocyclic(C0-C4 alkyl), heterocyclic(C1-C5 alkoxy)carbonyl, and heterocyclicsulfonyl,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, CN, and NO2;
- (19) alternatively, R12 and R13, when both are on the same nitrogen atom [as in (—NR12R13)] can be taken together with the nitrogen atom to which they are attached to form a heterocycle selected from 1-aziridinyl, 1-azetidinyl, 1-piperidinyl, 1-morpholinyl, 1-pyrrolidinyl, thiamorpholinyl, thiazolidinyl, and 1-piperazinyl,
- said heterocycle being optionally substituted with 0-3 groups selected from oxo, C1-C6 alkyl, C3-C7 cycloalkyl(C0-C4 alkyl)-, C1-C6 alkylcarbonyl, C3-C7 cycloalkyl(C0-C5 alkyl)carbonyl, C1-C6 alkoxycarbonyl, C3-C7 cycloalkyl(C0-C5 alkoxy)carbonyl, aryl(C0-C5 alkyl), heterocyclic(C0-C5 alkyl), aryl(C1-C5 alkoxy)carbonyl, heterocyclic(C1-C5 alkoxy)carbonyl, C1-C6 alkylsulfonyl arylsulfonyl and heterocyclicsulfonyl,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from the group consisting of CH3—, alkoxy, F, Cl, Br, CF3, CN, and NO2;
- (20) R14 is selected from the group consisting of H, C1-C10 alkyl, NO2, CF3, CN, F, Cl, Br, C1-C10 alkylcarbonyl, NR6R7(C0-C4 alkyl)-, R6C(═O)O(C0-C4 alkyl)-, R6OC(═O)O(C0-C4 alkyl)-, R6O(C0-C4 alkyl), R6R7NC(═O)O(C0-C4 alkyl)-, R6O2CCH2O(C0-C4 alkyl)-, R6OOC(C1-C4 alkoxy)-, R6OOC(C0-C4 alkyl)-, R6C(═O)(C0-C4 alkyl)-, R6C(═O)NR7(C0-C4 alkyl)-, R6OC(═O)NR7(C0-C4 alkyl)-, R6OC(═NCN)NR7(C0-C4 alkyl)-, R6R7NC(═O)NR8(C0-C4 alkyl)-, R6R7NC(═NCN)NR7(C0-C4 alkyl)-, R6R7NC(═C(H)(NO2))NR7(C0-C4 alkyl)-, R7R8N C(═NR7)NR7(C0-C4 alkyl)-, R6R7N SO2NR8(C0-C4 alkyl)-, R6SO2NR7(C0-C4 alkyl)-, R6S(C0-C4 alkyl)-, R6S(═O)(C0-C4 alkyl)-, R6SO2(C0-C4 alkyl)-, SO2NR6R7, SiMe3, R6R7N(C2-C4 alkyl)-, R6R7N(C2-C4 alkoxy)-, HSO3, HONH—, R6ONH—, R8R7NNR6—, HO(COR6)N—, HO(R6O2C)N, C2-C6 alkenyl, C3-C10 cycloalkyl, C3-C10 cycloalkylmethyl, aryl, heteroaryl, arylO—, and aryl(C1-C5 alkyl)-,
- wherein said aryl groups are substituted with 0-2 substituents independently selected from a group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, and NO2;
- (21) R15 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, and C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from R14;
- and
- (22) R16 is selected from the group consisting of H, C1-C8 alkyl, C3-C6 alkenyl, C3-C10 cycloalkyl(C0-C4 alkyl)-, aryl(C0-C4 alkyl)-, and heterocyclic(C0-C4 alkyl)-,
- wherein said aryl or heterocyclic groups are substituted with 0-2 substituents independently selected from R14;
- (23) alternatively, when R15 and R16 are on adjacent carbon atoms [as in —HR15C—CHR16—], or when R15 and R16 are oriented on the same side of the double bond [as in structure (III),
- 136
- R15 and R16 can be taken together with the carbon atoms to which they are attached to form a 3-7 membered carbocyclic aromatic or nonaromatic ring system, or a 3-7 membered heterocyclic aromatic or nonaromatic ring system, said carbocyclic or heterocyclic ring being optionally substituted with 0-2 substituents independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, F, Cl, Br, CF3, NO2.
39 more elements
Dependencies are inferred from the claim text.